Effect of subcutaneous recombinant human erythropoietin in cancer patients receiving radiotherapy: Preliminary results of a randomized, open-labeled, phase II trial

1993 ◽  
Vol 26 (4) ◽  
pp. 721-729 ◽  
Author(s):  
S Vijayakumar ◽  
Mack Roach ◽  
William Wara ◽  
Siu Kai Chan ◽  
Cynthia Ewing ◽  
...  
Keyword(s):  
Cancer Patients ◽  
Phase Ii ◽  
Recombinant Human Erythropoietin ◽  
Phase Ii Trial ◽  
Preliminary Results ◽  
Human Erythropoietin

Phase II Trial of Gemcitabine plus Trastuzumab in Metastatic Breast Cancer Patients Previously Treated with Chemotherapy: Preliminary Results

2002 ◽  
Vol 3 ◽  
pp. S17-S20 ◽  
Author(s):  
Joyce O'Shaughnessy ◽  
Svetislava J. Vukelja ◽  
Thomas Marsland ◽  
Gary Kimmel ◽  
Suresh Ratnam ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Cancer Patients ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Metastatic Breast ◽  
Breast Cancer Patients ◽  
Preliminary Results ◽  
Previously Treated

A phase II trial evaluating the clinical and immunologic response of HLA-A2+ non-small cell lung cancer patients vaccinated with an hTERT cryptic peptide

Lung Cancer ◽  
2014 ◽  
Vol 86 (1) ◽  
pp. 59-66 ◽  
Author(s):  
Athanasios Kotsakis ◽  
Elisavet Papadimitraki ◽  
Eleni Kyriaki Vetsika ◽  
Despoina Aggouraki ◽  
Eleftheria Kleio Dermitzaki ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Immunologic Response ◽  
Small Cell Lung ◽  
Lung Cancer Patients ◽  
Cryptic Peptide
Sign in / Sign up

Export Citation Format

Share Document